Isatuximab
Records for this ingredient, by country (identity only).
ATC L01FC02 · 11 markets · 28 records
JP 5 records · 5 shown of 5
- 500 mg/25 mLinjectionサークリサ点滴静注500mg
- 100 mg/5 mLinjectionサークリサ点滴静注500mg
- 1,400 mg/10 mLinjectionサークリサ皮下注1400mg
- 500 mg/100 mLinjectionアービタックス注射液500mg
- 100 mg/20 mLinjectionアービタックス注射液500mg
US 3 records · 3 shown of 3
GB 3 records · 3 shown of 3
- 500 mg/25 mLinjectionSarclisa 100mg/5ml concentrate for solution for infusion vials
- 100 mg/5 mLinjectionSarclisa 100mg/5ml concentrate for solution for infusion vials
- 1,400 mg/10 mLinjectionSarclisa 1400mg/10ml solution for injection vials
CA 3 records · 2 shown of 2
- 140 mg/1 mLliquidSARCLISA SC
- 20 mg/1 mLliquidSarclisa
AU 3 records · 2 shown of 2
- 500 mg per mL / per unit basis not statedinjectionSARCLISA isatuximab 500 mg/25 mL concentrated injection vial
- 100 mg per mL / per unit basis not statedinjectionSARCLISA isatuximab 500 mg/25 mL concentrated injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 2 records · 2 shown of 2
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 1 records · 1 shown of 1
- 20 mg/mL per mL / per unit basis not statedinjectionSARCLISA concentrate for solution for infusion 20 mg/mL
TW 1 records · 1 shown of 1
- 20 mg per mL / per unit basis not statedinjectionSARCLISA concentrate for solution for infusion 20 mg/mL多髓易濃縮輸注液20毫克/毫升
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 20 mg/1 mLinjectionSARCLISA 20 mg/mL, solution à diluer pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.